| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.21 | 0.001 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.19 | 0.002 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.2 | 0.002 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |